The US Food and Drug Administration (FDA) has issued a draft guidance outlining how manufacturers can ensure the data integrity of bioavailability (BA) and bioequivalence (BE) studies to support ...
Experts said that good manufacturing practice (GMP) violations, including inadequate procedures, insufficient training, and problems with data integrity, were commonly cited by US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results